Literature DB >> 28949390

STAT3 mediates resistance to anoikis and promotes invasiveness of nasopharyngeal cancer cells.

Chien-Hung Lin1, Ming-Chang Chiang2, Yann-Jang Chen1.   

Abstract

Nasopharyngeal carcinoma (NPC), a tumor arising from the epithelial cells of the nasopharynx, is endemic in Southeast Asia and Taiwan. The prognosis of NPC patients with local recurrence and metastasis is poor. Resistance to anoikis is a primary characteristic of tumor cells that metastasize. However, the mechanism through which NPC cells resist anoikis and are able to metastasize has not been fully elucidated. In the present study, the acquisition of anoikis resistance was analyzed in the TW01 and TW06 human NPC cell lines growing under anchorage-independent conditions. A considerable number of TW01 and TW06 cells was found to be resistant to anoikis and exhibited a higher capability of migration and invasion. These anoikis-resistant NPC cells exhibited significantly increased expression of signal transducer and activation of transcription 3 (Stat3) compared with adherent cells. Furthermore, blockade of STAT3 expression by STAT3 inhibitors or STAT3 silencing significant increased anoikis in anoikis-resistant NPC cells. Moreover, silencing STAT3 not only reduced the capacity of NPC cells to resist anoikis, but also reversed their invasive properties. The expression of epithelial‑to-mesenchymal transition‑related proteins and CD44 was also significantly decreased following STAT3 knockdown. The results of the present study established that STAT3 mediates anoikis resistance, with enhanced cell migration and invasion of NPC cells, and that activation of STAT3 may increase metastatic capacity, indicating the crucial role of STAT3 in conferring anoikis resistance and enhanced invasive properties to NPC cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28949390     DOI: 10.3892/ijmm.2017.3151

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

1.  Dihydromyricetin Exhibits Antitumor Activity in Nasopharyngeal Cancer Cell Through Antagonizing Wnt/β-catenin Signaling.

Authors:  Ling Ye; Gendi Yin; Miaohua Jiang; Bo Tu; Zhicheng Li; Yiming Wang
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

2.  SOCS3 gene silencing does not occur through methylation and mutations in gastric cancer.

Authors:  Atika Al Saqri; Shika Hanif Malgundkar; Fatima Al Kindi; Ishita Gupta; Mansour Al Moundhri; Yahya Tamimi
Journal:  Hum Cell       Date:  2022-05-21       Impact factor: 4.174

3.  Colony‑stimulating factor CSF2 mediates the phenotypic plasticity of small‑cell lung cancer by regulating the p‑STAT3/MYC pathway.

Authors:  Hui Li; Rui Zhong; Chunying He; Chenchen Tang; Heran Cui; Rixin Li; Yan Liu; Shaowei Lan; Ying Cheng
Journal:  Oncol Rep       Date:  2022-05-18       Impact factor: 4.136

4.  Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-β signaling pathway in nasopharyngeal carcinoma.

Authors:  Guoying Zou; Biqiong Ren; Yi Liu; Yin Fu; Pan Chen; Xiayu Li; Shudi Luo; Junyu He; Ge Gao; Zhaoyang Zeng; Wei Xiong; Guiyuan Li; Yumei Huang; Keqian Xu; Wenling Zhang
Journal:  Cancer Sci       Date:  2018-10-20       Impact factor: 6.716

5.  Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells.

Authors:  Yufei Yang; Yue Cao; Lihua Chen; Fei Liu; Zihao Qi; Xi Cheng; Ziliang Wang
Journal:  Cancer Med       Date:  2018-08-09       Impact factor: 4.452

6.  Involvement of MicroRNA-296 in the Inhibitory Effect of Epigallocatechin Gallate against the Migratory Properties of Anoikis-Resistant Nasopharyngeal Carcinoma Cells.

Authors:  Chien-Hung Lin; Hsin-Hui Wang; Tsung-Hsien Chen; Ming-Chang Chiang; Peir-Haur Hung; Yann-Jang Chen
Journal:  Cancers (Basel)       Date:  2020-04-15       Impact factor: 6.639

7.  RIPK4 Suppresses the Invasion and Metastasis of Hepatocellular Carcinoma by Inhibiting the Phosphorylation of STAT3.

Authors:  Haoran Li; Dingan Luo; Lakshmi Huttad; Mao Zhang; Youpeng Wang; Juan Feng; Yunfeng Ding; Bing Han
Journal:  Front Mol Biosci       Date:  2021-06-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.